Skip to content
Company Analysis

Indivior PLC INDV

A comprehensive view of key metrics, scores, and financial health for Indivior PLC

Overview of Indivior PLC

INDV NMS
Healthcare Drug Manufacturers - Specialty & Generic Mid Cap
Indivior PLC (INDV), is a Mid Cap company, in the Drug Manufacturers - Specialty & Generic industry, last closed at $31.11, about 27.8% overvalued vs fair value, +211.4% 1Y return, ranked 517/1110 in sector.
$31.11
0.81%
As of March 13, 2026
Previous close • Vol 90d: 31.5%
52-Week Range
Market Cap
$4.17B
Enterprise Value
$4.04B
Overall Score
Scores locked

Create a free account to see overall and pillar scores for Indivior PLC.

Top Beats

Quick Facts

Website https://www.indivior.com
HQ North Chesterfield, VA
Employees 1,030
Fiscal year Dec 31

Next Events

Earnings Apr 30 Estimated

Fair Value Snapshot

Bear Base Bull
$21
$22
$24
Current: $31.11 -28% vs base

Engine Room Money Flow™

Mid Cap

Pharmaceutical / Mature Biotech - Where revenue goes and how value is created

Flow Steps
Total Revenue
$1.2B
4.3%%
Gross Profit
$994.0M
3.9%%
R&D Expense
$97.0M
-9.3%%
Operating Income (EBIT)
$284.0M
416.4%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Pharmaceutical / Mature Biotech

Quality & Reliability Indicators

Cash Conversion
-9.5%
Poor

Weak cash conversion - investigate working capital

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Owner's Pocket - Capital Allocation

Total Returned to Shareholders

Combined dividends, buybacks, and debt reduction

$11.0M
220.0% of FCF

Where It Leaks

Cash Flow Health some concerns
Moderate efficiency issues detected. Review active leaks below for improvement areas.
2
Active Leaks
0/2
Improving
1
High Impact
0
Critical
Locked Leak
Upgrade to view details
Premium
Moat Analysis Corporate Default

Competitive Advantage Assessment

Evaluating Indivior PLC's durable competitive advantages across 6 defense dimensions

Overall Moat Strength
63
/100
Moderate
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power

Strong
88
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Generic Industrial / Default vs Industry Peers 97% Coverage
Trade-Off Triangle Visualization A ternary plot showing INDV's balance between Growth (32.1%), Profitability (39.0%), and Safety (28.9%). Growth 32% Safety 29% Profitability 39%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

55th percentile vs peers
55
Key Signals
EPS Growth YoY 1.02 91p Revenue CAGR 3Y 11.2% 63p Rev Growth YoY 4.3% 46p EPS CAGR 3Y -77.5% 12p
Strengths
  • Eps Growth Yoy in top 20% of peers (1.02, 91th percentile)
  • Interest Coverage Ratio in top 20% of peers (6.31, 87th percentile)
  • Superior capital returns - 2 return metrics above peer median
  • Operating Margin in top 20% of peers (21.1%, 88th percentile)
Risks

No significant risks identified for this axis.

Profitability

67th percentile vs peers
67
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

49th percentile vs peers
50
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Indivior PLC.

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$22.46
- - -
-27.8% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info